Ignite Creation Date:
2024-05-05 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 9:46 AM
Study NCT ID:
NCT00637221
Status:
COMPLETED
Last Update Posted:
2012-04-27
First Post:
2008-03-03
Brief Title:
Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks Adults With Fragile X Syndrome
Sponsor:
Neuropharm
Organization:
Neuropharm
Study Overview
Official Title:
An Open Label Exploratory Study to Investigate the Safety and Effects of NPL-2009 50 mg - 150 mg Single Dose on Prepulse Inhibition Tests and Continuous Performance Tasks in Adults With Fragile X Syndrome
Status:
COMPLETED
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open label exploratory study to investigate the safety and effects of a single dose of NPL-200950 mg - 150 mg on Prepulse Inhibition PPI Tests and Continuous Performance Tasks CPT in adults with Fragile X Syndrome
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None